They are the big dogs of modern mergers and acquisitions (M&As) — rapacious dealmakers that have devoured mighty corporations, bankrolled young disrupters and upended entire industries. And they are not looking so tough anymore.
Since 2014, when the latest wave of mergers and acquisitions began to build, three names have inspired fear and envy in the M&A world. In doing so, each has been totemic of a particular vogue in the capital markets:
3G Capital, the Brazilian investment firm that has picked off some of the US’ most famous brands and aggressively squeezed out costs and jobs; Valeant Pharmaceuticals, the ill-fated Canadian company that gobbled up drugmakers, drove up prices and fueled outrage over high prescription costs; and Softbank Group Corp, the big-dreaming — and big-spending — Japanese conglomerate that has backed the likes of Uber Technologies Inc and WeWork and remains one of the most powerful forces in Silicon Valley.
From the start, the three M&A powerhouses adopted wildly different strategies.
However, for any investor, the similarities deserve attention. Wall Street believed them and their many imitators to be exceptional. Turns out, they were not, and are not.
That is worth remembering at a moment when financial world is struggling to come to grips with the yawning gap between what the pros think companies are worth and what those companies actually fetch on public markets — see WeWork’s botched initial public offering.
Not long ago, 3G, cofounded by billionaire Jorge Paulo Lemann, seemed unstoppable. Lemann became a global name by cobbling together the world’s biggest beermaker, Anheuser-Busch InBev; picking up brands like Burger King and Tim Hortons; and driving the 2015 merger between Kraft and Heinz to create one of world’s largest food companies.
3G has since stumbled — hard. Mixing Kraft Foods Inc and HJ Heinz Co turned out to be a disastrous idea, and not just for those two companies.
The investment firm’s usual combine-and-cut formula failed miserably at Kraft Heinz Co.
Since Lemann teamed up with none other than Warren Buffett to do the deal, sales and profits have tanked. 3G’s dream of turning Kraft Heinz into the savior of Big Food ended when Unilever rebuffed its US$143 billion takeover offer in 2017.
In February, Kraft Heinz took a staggering US$15.4 billion writedown. The company’s stock has plunged more than 70 percent from its peak, helping to drag down rivals like Kellogg Co, Campbell Soup Co and General Mills Inc.
Former management consultant Michael Pearson had a similarly radical idea at Valeant: that drugmakers like itself had no business actually making drugs.
Instead, it would borrow money to acquire rivals, dramatically increase the price of their treatments and fire almost everyone. Rinse, repeat.
Valeant’s ambition peaked in 2014, when it teamed up with activist investor Bill Ackman to mount an audacious US$54 billion takeover offer for Allergan PLC, the maker of Botox.
The bid was spurned, but Ackman and Pearson were undimmed and, as if to prove their theory, took the company on a buying spree that included gastrointestinal drugmaker Salix Pharmaceuticals Inc (US$11.1 billion) and Sprout Pharmaceuticals Inc, a developer of female libido stimulants (US$1 billion).
For a while investors approved, sending Valeant’s market value to US$90 billion in August 2015. Then things went spectacularly wrong.
Accounting irregularities, mounting debts and political angst over surging drug prices destroyed not only the Valeant dream, but those of the entire specialty pharmaceuticals industry.
Shares of Valeant are 93 percent lower, with a new management, board and shareholder base, and has renamed itself Bausch Health Companies Inc.
There is no nice way to bring Softbank into this part of the story.
By almost any conceivable measure, it is having a diabolical year. The quixotic Masayoshi Son, a start-up kingmaker of undoubted brilliance, has staked Softbank’s billions — and its reputation — on three companies: Uber, the ride-hailing app which has lost about a third of its value, or US$19 billion, since its May IPO; Slack, a messaging platform, which debuted in June and is down 35 percent from where it ended its first trading day; and WeWork.
The scale of these blowups, so starkly at odds with Softbank’s recent esteemed status, has dislocated the US IPO markets as investors and would-be public companies look skeptically at one another across a widening gulf of value perception.
In hindsight, the impermanence of the three dealmakers’ strategies is easy to skewer.
However, the success of 3G and Valeant was fueled by some of the most well-known names in finance. Softbank, meanwhile, tapped entire nations to bankroll its ambitions of creating a future of robot-human harmony.
These failures could end up restricting Son’s access to funding, but it is unlikely to diminish his vision for what he has said is a 300-year plan to grow the company he started 38 years ago.
Nor, probably, will it dampen his enthusiasm for what he has called the gold rush of investing in nascent technology.
“It’s just a money thing. It’s not important, it’s just a process. What is more important is humans’ happiness? How do we help ourselves, humans, become happier?” Son said in 2017, calling himself a “super optimist.”
“There’s always a solution,” he said.
What is more likely is the end of the burgeoning trend of taking loss-making companies public in the hope the future will come to them.
Perhaps, too, some doubt will attach itself to the idea that pumping a young business with money and expecting it to succeed is not an idea of wheel-inventing novelty.
Either way, there will be something else to worship soon enough. There always is.
BULK PURCHASE: The French chain and Hong Kong-based Dairy Farm International reached a deal covering 224 stores, which is expected to be finalized by year’s end Carrefour SA yesterday announced it would acquire Wellcome Taiwan Co (惠康百貨) for 97 million euros (US$108.33 million), and bring all the Wellcome supermarkets (頂好超市) and Jasons Market Place stores nationwide under its banner within 12 months of the deal closing. The France-based hypermarket chain reached an agreement with Hong Kong-based Dairy Farm International Holdings (牛奶國際控股), the pan-Asian retailer that launched Wellcome Taiwan in 1987. The transaction involves 199 Wellcome supermarkets, which have average sales areas of 420m2 and 25 high-end Jasons Market Place stores, which have an average sales area of 820m2, as well as a warehouse in Taoyuan, Carrefour Taiwan (家樂福)
‘ONE-STOP SHOP’: A Miaoli official said that the factory in the Jhunan section of the Hsinchu Science Park would create more than 1,000 jobs and boost prosperity A new high-end IC packaging and testing plant planned by contract chipmaker Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) in Miaoli County is expected to start operations in the middle of next year, Miaoli County Commissioner Hsu Yao-chang (徐耀昌) said. Hsu wrote on Facebook that TSMC, the world’s largest pure wafer foundry operator, would invest NT$303.2 billion (US$10.1 billion) to build the plant, the largest-ever single investment in Taiwan. However, TSMC declined to disclose the financial terms of the deal, while a company board meeting on May 12 approved a spending plan worth NT$168.2 billion as part of its investment plans. Construction of the
SCATTERED: Production would be dispersed among a number of countries, which would bring an end to so-called world factories, Hon Hai chairman Young Liu said Decentralized production would be the new focus in manufacturing, Hon Hai Precision Industry Co (鴻海精密) chairman Young Liu (劉揚偉) yesterday told an online forum held by the Market Intelligence & Consulting Institute (MIC, 產業情報研究所). “The COVID-19 pandemic exerted a heavy impact on supply chains as well as production ... [production] would no longer be concentrated in solely one country, this is the end of what we used to call world factories,” Liu said during a panel discussion hosted by MIC director Victor Tsan (詹文男). As the US and China continue to dominate and sway international relations, the rest of the world is
PLANNED OUT: The government is lifting sale and export restrictions on 60% of the 20 million masks made daily, but people can still make purchases using their NHI cards Twenty thousand boxes of 50 masks each would be on sale at FamilyMart convenience stores starting tomorrow, Taiwan FamilyMart Co Ltd (全家便利商店) said yesterday. A box of 50 masks would cost NT$249 for those with FamilyMart memberships and NT$299 for those without, with no limits placed on how many boxes a person can buy, the company said. Convenience store chain operator Hi-Life International Co Ltd (萊爾富) said that it would also start selling masks from tomorrow. It has yet to announce details about prices and quantity. Hypermarket chain operator Carrefour Taiwan (家樂福) said that it would start selling packs of five